Greenwich LifeSciences enters $100M ATM equity offering agreement with Jefferies

Greenwich LifeSciences, Inc.

Entered Open Market Sale Agreement with Jefferies LLC for at-the-market offering of common stock up to $100M.
Commission rate of up to 3.0% of gross proceeds; Jefferies gets customary indemnification.
Proceeds intended for general corporate purposes including GP2 clinical development, R&D, working capital.
No obligation to sell any shares; company can suspend offering.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.